Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devesh Srivastava

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Food and Drug Law Journal|August 10, 2004
The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entryDevesh Srivastava
Non-Coding RNA Research|October 13, 2025
Long non-coding RNAs in B-cell acute lymphoblastic leukemia: Disease implication, challenges and therapeutic opportunitiesDevesh Srivastava, Ashish Misra
Molecular and Cellular Pediatrics|November 17, 2025
Widespread prevalence of CD19 exon 5-6 skipping in primary pediatric B-Cell acute lymphoblastic leukemia patientsDevesh Srivastava, Anurag Gupta, Nishant Verma, et al.
Cancer Reports (Hoboken, N.J.)|February 13, 2025
Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 (IGF2BP2) Promotes Castration-Resistant Prostate Cancer Progression by Regulating AR-V7 mRNA StabilityTaruna Saini, Devesh Srivastava, Rajnikant Raut, et al.
Cytokine|August 9, 2025
Epitranscriptomic regulation of immunity: The role of m6A in shaping immune response dynamicsDevesh Srivastava, Vinayak Nayak, Srijoni Pahari, et al.
Ageing Research Reviews|March 29, 2021
Post-translational modifications: Regulators of neurodegenerative proteinopathiesRohan Gupta, Mehar Sahu, Devesh Srivastava, et al.
Molecular Diversity|April 12, 2021
Artificial intelligence to deep learning: machine intelligence approach for drug discoveryRohan Gupta, Devesh Srivastava, Mehar Sahu, et al.
Discover Oncology|August 7, 2025
Integrative analysis identifies FBXO5 as a critical mediator of CRPC progression and bone metastatic potentialRajnikant Raut, Devesh Srivastava, Amit Kumar Chakraborty, et al.
Analytical Chemistry|June 9, 2007
Nanostructured biosensor for measuring neuropathy target esterase activityNeeraj Kohli, Devesh Srivastava, Jun Sun, et al.
Journal of Colloid and Interface Science|April 8, 2014
Dynamic encapsulation of hydrophilic nisin in hydrophobic poly (lactic acid) particles with controlled morphology by a single emulsion processShaowen Ji, Jue Lu, Zhiguo Liu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Food and Drug Law Journal|August 10, 2004
The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entryDevesh Srivastava
Non-Coding RNA Research|October 13, 2025
Long non-coding RNAs in B-cell acute lymphoblastic leukemia: Disease implication, challenges and therapeutic opportunitiesDevesh Srivastava, Ashish Misra
Molecular and Cellular Pediatrics|November 17, 2025
Widespread prevalence of CD19 exon 5-6 skipping in primary pediatric B-Cell acute lymphoblastic leukemia patientsDevesh Srivastava, Anurag Gupta, Nishant Verma, et al.
Cancer Reports (Hoboken, N.J.)|February 13, 2025
Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 (IGF2BP2) Promotes Castration-Resistant Prostate Cancer Progression by Regulating AR-V7 mRNA StabilityTaruna Saini, Devesh Srivastava, Rajnikant Raut, et al.
Cytokine|August 9, 2025
Epitranscriptomic regulation of immunity: The role of m6A in shaping immune response dynamicsDevesh Srivastava, Vinayak Nayak, Srijoni Pahari, et al.
Ageing Research Reviews|March 29, 2021
Post-translational modifications: Regulators of neurodegenerative proteinopathiesRohan Gupta, Mehar Sahu, Devesh Srivastava, et al.
Molecular Diversity|April 12, 2021
Artificial intelligence to deep learning: machine intelligence approach for drug discoveryRohan Gupta, Devesh Srivastava, Mehar Sahu, et al.
Discover Oncology|August 7, 2025
Integrative analysis identifies FBXO5 as a critical mediator of CRPC progression and bone metastatic potentialRajnikant Raut, Devesh Srivastava, Amit Kumar Chakraborty, et al.
Analytical Chemistry|June 9, 2007
Nanostructured biosensor for measuring neuropathy target esterase activityNeeraj Kohli, Devesh Srivastava, Jun Sun, et al.
Journal of Colloid and Interface Science|April 8, 2014
Dynamic encapsulation of hydrophilic nisin in hydrophobic poly (lactic acid) particles with controlled morphology by a single emulsion processShaowen Ji, Jue Lu, Zhiguo Liu, et al.
Pageof 2